Asset
DARINAPARSIN
Alaunos Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00592046 | phase1 | completed | 2005-05-01 | 2008-06-01 | Alaunos Therapeutics | A Phase I Trial of ZIO-101 in Hematologic Cancers |
| NCT00591396 | phase1 | completed | 2005-07-01 | 2008-07-01 | Alaunos Therapeutics | A Phase I Trial of ZIO-101 in Solid Tumors |
| NCT00303199 | phase1_2 | completed | 2006-01-01 | 2007-08-01 | Alaunos Therapeutics | Study of ZIO-101 in Multiple Myeloma |
FDA applications (0)
This company has no applications containing this asset.